Shionogi & Co., Ltd. et al v. Norwich Pharmaceuticals, Inc. et al
| Genentech, Inc., Hoffmann-La Roche Inc. and Shionogi & Co., Ltd. |
| Norwich Pharmaceuticals, Inc. and Alvogen Pb Research & Development LLC |
| 1:2024cv01264 |
| November 18, 2024 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 9, 2025. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alvogen Pharma US, Inc. for Alvogen Pb Research & Development LLC, Norwich Pharmaceuticals, Inc. filed by Norwich Pharmaceuticals, Inc., Alvogen Pb Research & Development LLC. (Hoeschen, Nathan) |
| Filing 10 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to February 10, 2025 - filed by Norwich Pharmaceuticals, Inc., Alvogen Pb Research & Development LLC. (Hoeschen, Nathan) |
SO ORDERED re #10 STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the Complaint to February 10, 2025 (Set/Reset Answer Deadlines: Alvogen Pb Research & Development LLC answer due 2/10/2025; Norwich Pharmaceuticals, Inc. answer due 2/10/2025). ORDERED by Judge Maryellen Noreika on 1/9/2025. (dlw)
|
| Filing 9 SUMMONS Returned Executed by Hoffmann-La Roche Inc., Shionogi & Co., Ltd., Genentech, Inc..Alvogen Pb Research & Development LLC served on 12/19/2024, answer due 1/9/2025. (Jacobs, Karen) |
| Filing 8 SUMMONS Returned Executed by Hoffmann-La Roche Inc., Shionogi & Co., Ltd., Genentech, Inc..Norwich Pharmaceuticals, Inc. served on 12/19/2024, answer due 1/9/2025. (Jacobs, Karen) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) |
| Filing 7 Summons Issued as to Alvogen Pb Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Attachments: #1 Summons Issued Norwich Pharma Inc.)(scs) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holding Ltd., Corporate Parent Roche Holdings, Inc. for Genentech, Inc., Hoffmann-La Roche Inc. filed by Hoffmann-La Roche Inc., Genentech, Inc.. (scs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd.. (scs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,064,438. (scs) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 10/09/2039. (scs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
| Filing 1 COMPLAINT for Patent Infringement (ANDA) against Norwich Pharmaceuticals, Inc. and Alvogen Pb Research & Development LLC (Filing fee $ 405, receipt number ADEDC-4551547) - filed by Hoffmann-La Roche Inc., Shionogi & Co., Ltd., Genentech, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(scs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
